跳至主要内容
临床试验/ISRCTN14050335
ISRCTN14050335进行中(未招募)未知

A cross-sectional trial assessing the clinical utility of pre-emptive pharmacogenetic testing in primary and secondary care: the Implementing Pharmacogenetics to Improve Prescribing (IPTIP) trial

niversity of Manchester0 个研究点目标入组 646 人开始时间: 2022年6月23日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
646

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Participants must be admitted to the Manchester University NHS Foundation Trust or attend an outpatient appointment, as a patient or relative, at the Manchester University NHS Foundation Trust
  • 2. Participants must have the capacity to independently consent
  • 3. Patients must be over the age of 18 years

排除标准

  • 1. Patients unable to independently consent
  • 2. Patients under the age of 18 years

研究者

发起方
niversity of Manchester

相似试验